BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/22/2026 6:51:26 AM | Browse: 32 | Download: 4
Publication Name World Journal of Gastroenterology
Manuscript ID 121267
DOI 10.3748/wjg.121267
Country China
Category Gastroenterology & Hepatology
Manuscript Type Observational Study
Article Title Diagnostic efficacy of fecal calprotectin combined with a high-sensitivity quantitative fecal immunochemical test for colorectal tumors
Manuscript Source Unsolicited Manuscript
All Author List Wei Jing, Lei Qin, Xiao-Han Zhang, Fei Pan, Rong-Rong Ren, Yan Li, Yan Zhang, Li-Hua Peng, Zi-Kai Wang and Xiu-Li Zhang
Funding Agency and Grant Number
Corresponding Author Xiu-Li Zhang, Chief, MD, PhD, Microbiota Division, Department of Gastroenterology and Hepatology, The First Medical Center of Chinese People’s Liberation Army (PLA) General Hospital, No. 28 Fuxing Road, Haidian District, Beijing 100853, China. zhangxl70@126.com
Key Words Colorectal tumors; Colorectal cancer; Advanced adenoma; Fecal immunochemical test; Fecal calprotectin; Diagnostic efficiency
Core Tip Fecal calprotectin is a calcium-containing antimicrobial protein complex. Currently, it is primarily used in clinical practice for the diagnosis and monitoring of inflammatory bowel disease; however, its diagnostic value in colorectal tumors remains to be established. This paper draws a preliminary conclusion that fecal calprotectin can serve as a reliable biomarker for colorectal cancer. When combined with the fecal high-sensitivity quantitative immunochemical test, calprotectin increases the sensitivity for diagnosing colorectal cancer to 87.5%, raises the negative predictive value to 82.8%, and achieves an area under the receiver operating characteristic curve of 0.866. The combination of two biomarkers enhances the diagnostic efficacy for colorectal tumors.
Citation Jing W, Qin L, Zhang XH, Pan F, Ren RR, Li Y, Zhang Y, Peng LH, Wang ZK, Zhang XL. Diagnostic efficacy of fecal calprotectin combined with a high-sensitivity quantitative fecal immunochemical test for colorectal tumors. World J Gastroenterol 2026; In press
PDF 121267-in-press.pdf
Received
2026-03-20 13:30
Peer-Review Started
2026-03-20 13:32
First Decision by Editorial Office Director
2026-05-08 10:05
Return for Revision
2026-05-08 10:05
Revised
2026-06-02 12:21
Publication Fee Transferred
2026-06-08 05:55
Second Decision by Editor
2026-06-22 02:38
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-22 06:51
Articles in Press
2026-06-22 06:51
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com